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ScienceDirectSeveral neuropsychiatric and neurodegenerative disorders are
characterised by motivational impairments manifested as lack
of behavioural activation or energy resulting in significant
functional impairment. Given the clinical significance of these
symptoms, the study of motivation in preclinical research has
recently intensified. This review briefly summarises the tasks
that have been implemented for the evaluation of motivation in
different species, emphasising the recent use of touchscreen-
based rodent testing systems. This methodology has been
widely used in the evaluation of multiple cognitive domains
emphasising their translational value and flexibility. Recently
touchscreen-based versions of classical tasks for the
evaluation of motivation have been or are currently being
developed and validated, thus facilitating translation from
animal to human research and promoting their implementation
in clinical contexts.
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Introduction
Motivation is typically defined as the set of adaptive
processes by which organisms orient and initiatewww.sciencedirect.com behaviour towards or away from salient internal and
environmental stimuli [1,2]. It is complex and multifac-
eted, encompassing directional, activational and effort-
related components [1,3]. To successfully adapt to the
environment, organisms must direct and activate appro-
priate behaviour in response to significant stimuli and
assign a suitable degree of effort based on work-related
assessments, preferences or motivational value. These
abilities are disrupted in a wide range of mental illnesses,
including depression, dementia, Huntington’s Disease,
Parkinson’s Disease and schizophrenia [4–7].
Clinically, deficits in motivation are typically termed
apathy or anergia, which encompass loss or diminishment
of goal-directed behaviour and/or cognitive activity [8]
and lack of behavioural activation with consequent
impairments in important areas of function [9]. These
symptoms result in profound functional disability for
patients, reduced quality of life for them and their care-
givers and can lead to earlier institutionalisation [10].
Despite the highly deleterious nature of these symptoms,
there are few targeted therapeutics available for amelio-
rating them.
To better address this issue, a greater understanding of
the neurobiological mechanisms underlying motivation
and how these are disrupted in various disease states will
be required. The development and optimisation of pro-
cedures to assess motivation in preclinical disease models
will therefore be of substantial benefit. Ensuring these
procedures have high levels of translational validity is also
essential to maximise the likelihood of successful delivery
of promising therapeutics to the clinic.
Rodent touchscreen-based tests offer a number of advan-
tages including similarity with computerised cognitive
assessments increasingly used clinically [11] and are
versatile pre-clinical tools for the assessment of motiva-
tion in rodent models [12,13]. In this review we discuss
methods for the study of motivation in laboratory rodents
and recent developments of tests instantiated in the
touchscreen apparatus. Implications for the translation
of results obtained in rodents towards the development
of therapeutics directed at ameliorating apathy are
discussed.Current Opinion in Behavioral Sciences 2018, 22:21–27
22 Apathy and motivationCurrent methods for studying motivation in
animals
Effort-based decision-making and tasks requiring sus-
tained vigorous responding are the most common tools
for evaluating motivation in animals [2]. Performance
impairments are considered to mirror the apathy observed
in various patient groups [1,2,14]. These studies have
frequently focused on the mesolimbic dopamine (DA)
system as a key component in the neural circuitry that
regulates behavioural activation, effort allocation and the
ability of organisms to overcome work-related response
challenges [14,15]. This maps well on to the sub-construct
of ‘willingness to work’ that has been characterised in
the RDoc framework as a major factor in ‘approach
motivation’ [16], thus emphasising the importance of
identifying the neural substrates of these transdiagnostic
dimensions across species.
One widely used procedure is the Progressive Ratio (PR)
task [17], which assesses motivation by measuring the
ability of an animal to maintain responding in order to
obtain a reinforcer in the face of increasing response
requirements. PR is typically performed in operant cham-
bers in which animals are required to press a lever or enter
a nose poke to get a valuable reward [18,19]. This task
measures the maximum number of responses that animals
are willing to emit to obtain the reinforcer, known as the
‘breakpoint’. Although PR has been widely used in
rodents and non-human primates [20,21], more recent
studies of motivation have used Effort-Related Choice
(ERC) tasks that require animals to choose between high
effort actions such as repeated lever pressing on a variety
of ratio schedules leading to highly valued reinforcers (e.
g. sweet pellets, sucrose solution or exercise) versus an
alternative low effort/low reward value option (e.g. freely
available standard laboratory food) [18,22–25].
A valuable addition to the range of tasks that is typically
performed in operant chambers is the effort discounting
(ED) task which was originally developed for rats and has
been recently adapted for mice [26,27]. In ED, subjects
are offered a choice between two instrumental responses
(e.g. lever-press) one of which yields a larger magnitude
reinforcer. Over the course of a session, the response
requirement for the large reward gradually increases,
whereas only a single response in needed to obtain the
smaller one [28]. Together with the delay discounting
task (DD), in which a gradually increasing delay is asso-
ciated with the large reward option, ED has helped to
identify various brain areas and neurochemical mecha-
nisms involved in the regulation of effort or delay related
processes during decision making [27,29].
Mazes have been also used to study effort-based decision
making in rodents. One example is the T-maze barrier
task that was first designed for rats and adapted for mice
[30,31]. In this task, the two choice arms of a T-mazeCurrent Opinion in Behavioral Sciences 2018, 22:21–27 contain different amounts of reinforcer (e.g. one versus two
sucrose pellets) and provide a work-related challenge with
a vertical barrier placed across the arm with the higher
reward density [23,30,31]. A more recent development is a
novel T-maze based task in which animals choose between
exercising in a running wheel or eating freely available
sweet pellets [25]. Running requires effort expenditure but
also has reinforcing properties that enable it to be used as
the reward for the ‘high effort’ option in the context of
effort-based decision making [25].
ERC tasks, unlike PR, provide a better understanding of
activational and directional components of motivation
[1]. Although both tasks are sensitive to the same
manipulations (e.g. DA receptor antagonists or DA deple-
tion) [12,23,25,27,32], ERC tasks evaluate whether a
given manipulation affects the primary properties of the
reinforcer. For example, a manipulation that decreases
PR breakpoint, when evaluated in ERC may not result in
a generalised decrease in operant output but instead
causes the reallocation of behavioural resources from
the more effortful but preferred reward option to the less
preferred but less effortful option available in these tasks.
Such behavioural shift is consistent with the manipulation
affecting effort-related outcomes (such as willingness to
work) without affecting other processes such as ‘reward
valuation’ [1,30].
Translating animal motivational assessments
to humans
Given its clinical significance [33], the quantitative
assessment of motivation in humans is increasingly
important. Such behaviours have traditionally been
assessed via questionnaire-based measures, aimed at
assessing pathological disruptions in motivation. These
include either subsets of inventories [34] or specific scales
[35,36]. However, in addition to limitations associated
with such assessments such as recall bias, linking these to
assessments used in experimental animals such as PR and
ERC is problematic [37]. As a result, a number of
research groups have suggested the use of behavioural
measures of specific constructs such as reward anticipa-
tion [38] and effort exertion [5] and a few have achieved
successful translation of some of the preclinical assays.
For example, PR has been adapted for use in humans and
although several different versions exist [39–41], all assess
the ability to maintain responding for a (monetary) reward
under increasing work requirements. As in rodent PR,
responding consists of a cognitively non-demanding task,
such as selecting the largest number [41] or repeatedly
pressing a button [39] with breakpoint being the primary
outcome measure.
As discussed previously, ERC assays have been widely
used in preclinical settings. Treadway and colleagues
have developed a human analogue of ERC known as
the Effort-Expenditure for Rewards Task (EEfRT)www.sciencedirect.com
Use of touchscreen-based systems for assessing motivation Phillips et al. 23[42,43]. Like ERC, EEfRT allows subjects to choose
between a high-effort high-reward and a low-effort low-
reward option. Effort is manipulated by requiring subjects
to complete a number of button presses within a given
period of time. Several EEfRT studies have replicated
rodent ERC findings. For example, administration of
amphetamine in animals and humans can increase selec-
tion of the high effort-high reward option [27,44]. Fur-
thermore, the results of a positron emission tomography
(PET) study in humans highlighted the role of dopami-
nergic activity within the ventral striatum in high-effort
choice selection in EEfRT which mirrors the effects ofFigure 1
Standard mouse Bussey Saksida touchscreen chambers (Campden Instrum
attenuating chamber not shown.
www.sciencedirect.com dopamine depletion in equivalent structures in animals
performing ERC [45,46].
Together, these studies highlight how certain constructs
related to motivation can be assessed using paradigms
adapted in species-specific ways. It may be possible,
however, to further increase the success of cross species
translation through the use of automated touchscreen
operant systems. Although non-touchscreen based ERC
tasks have been successfully back translated from animal
to human research [42], the development of new
touchscreen-based motivational tasks in both humansCurrent Opinion in Behavioral Sciences 
ents Ltd., Loughborough, UK). View from the top. Surrounding sound
Current Opinion in Behavioral Sciences 2018, 22:21–27
24 Apathy and motivationand rodents with a high degree of similarity between
them could facilitate the comparison of results obtained
across species. In addition, back and forward translation
has already been demonstrated with touchscreen-based
tasks focused on cognitive abilities [11,47,48].
Touchscreen-based tasks as a new tool for
evaluating motivation in different species
Until recently, the majority of research using touchsc-
reen-equipped systems (see Figure 1) has focused on
cognitive domains such as attention, memory and execu-
tive function [49–51].
The substantial translational potential of touchscreen-
delivered assessment in humans and animals is exempli-
fied by a series of studies of the gene Dlg2. Specifically,
cognitive assessment of humans using the touchscreen-
based CANTAB system and evaluation of mice using
analogous rodent touchscreen tasks yielded similar cross-
species performance profiles in groups with Dlg2 muta-
tions [50]. Importantly, subsequent use of an identical
version of the touchscreen paired associates learning
(PAL) task to evaluate humans and mice with Dlg2
mutations also yielded a performance profile common
between species [47,49].
To capitalise on this translational potential, a number of
touchscreen-based assays targeting motivation including
PR, ERC and ED have been validated for use in mice
[12,52, Lopez-Cruz et al., unpublished], rats [Hailwood
et al., unpublished] and non-human primates [52,53].
Additionally, a human touchscreen PR task has been
developed as part of the EMOTICOM affective cogni-
tion assessment battery [54]. The EMOTICOM PR, like
other human versions, consists of completing a simpleFigure 2
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tary reward. This version of PR, therefore, can be con-
sidered analogous to the preclinical touchscreen version
and generates the same profile of outcome measures,
including breakpoint, running rate and post reinforce-
ment pause [12]. Tasks that feature objective and
quantitative measures between species represent an
improved approach to measuring similar underlying cog-
nitive processes as has been demonstrated in previous
studies [47].
The EMOTICOM battery also contains DD task.
Although DD is often used as a test for the assessment
of impulsive decision-making in rodents, it is also used in
combination with ED as a measure of how much time
animals are willing to wait for a larger/more preferred
reinforcer and therefore can provide insight into motiva-
tional state. A DD variant has been recently adapted and
validated for mice in the touchscreen apparatus [Phillips
et al., 2017, unpublished] providing another opportunity
for translation between the human and rodent assessment
platforms.
The development and validation of tasks to assess moti-
vation, effort and effort-associated decision making in
rodents using touchscreen-equipped systems [12,13,55]
enables the inherent advantages of this methodology to
be applied to research areas beyond investigation of the
well-established cognitive domains for which this manip-
ulandum is widely used [49,56,57]. Given the exclusion of
explicitly aversive stimuli from touchscreen-delivered
tasks, and the consistent testing environment, it is possi-
ble to integrate a variety of different tasks into a unified
assessment battery [49] that can be used to evaluate
multiple psychological constructs in the same animal.Identification and
lidation of targets
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Use of touchscreen-based systems for assessing motivation Phillips et al. 25The integration of motivation and effort-related tasks into
batteries consisting of cognitive assessments will substan-
tially enhance data yields and enable detailed studies of
the interaction between motivation, effort and cognitive
performance in the same individual in the same appara-
tus. This approach will eliminate issues related to
between-subject designs impeding efforts to correlate
performance across tasks and any potential confounds
associated with the use of different apparatus to evaluate
different constructs, consistent with the 3Rs principles of
reduction and refinement [58].
Conclusions
Although much development remains to be completed,
forward-translation and back-translation between pre-
clinical models and clinical populations, facilitated by
the use of analogous interspecies touchscreen-based
assays, has the potential to provide substantial insight
into the neurobiological underpinnings of apathy, offer a
powerful platform for therapeutic screening and provide a
quantitative read-out of behaviour unconfounded by
observer/recall bias to complement more subjective mea-
sures obtained via clinical questionnaire-based instru-
ments (see Figure 2).
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